Pegylated Liposomal Doxorubicin (Caelyx(®)) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial

Background: Adjuvant chemotherapy for Luminal B-like breast cancers usually includes anthracycline-based regimens. However, some patients are reluctant to receive chemotherapy because of side-effects, especially alopecia, and ask for a “less intensive” or personalized approach. Patients and methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Dellapasqua, Silvia, Trillo Aliaga, Pamela, Munzone, Elisabetta, Bagnardi, Vincenzo, Pagan, Eleonora, Montagna, Emilia, Cancello, Giuseppe, Ghisini, Raffaella, Sangalli, Claudia, Negri, Mara, Mazza, Manuelita, Iorfida, Monica, Cardillo, Anna, Sciandivasci, Angela, Bianco, Nadia, De Maio, Ana Paula, Milano, Monica, Campennì, Giuseppe Maria, Sansonno, Loredana, Viale, Giuseppe, Morra, Anna, Leonardi, Maria Cristina, Galimberti, Viviana, Veronesi, Paolo, Colleoni, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700739/
https://www.ncbi.nlm.nih.gov/pubmed/34940072
http://dx.doi.org/10.3390/curroncol28060433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700739/
https://www.ncbi.nlm.nih.gov/pubmed/34940072
http://dx.doi.org/10.3390/curroncol28060433

Ejemplares similares